awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33430690-729EC35C-ADD2-49E3-9543-B8E90513D232
Q33430690-729EC35C-ADD2-49E3-9543-B8E90513D232
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33430690-729EC35C-ADD2-49E3-9543-B8E90513D232
Carfilzomib Triple Combination Therapy: A Review in Relapsed Multiple Myeloma.
P2860
Q33430690-729EC35C-ADD2-49E3-9543-B8E90513D232
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33430690-729EC35C-ADD2-49E3-9543-B8E90513D232
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e896bdf648aab8b8e6a3376782edf91b0a60e2c
P2860
A phase I single-agent study of twice-weekly consecutive-day dosing of the proteasome inhibitor carfilzomib in patients with relapsed or refractory multiple myeloma or lymphoma.